Company profile for Lobe Sciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Lobe Sciences is a life sciences company focused on psychedelic medicines. The company, through collaborations with industry leading partners, is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechanisms to improve mental health and wellness. The company is also developing transformative medicines to treat Orphan diseases to benefit patients of all ag...
Lobe Sciences is a life sciences company focused on psychedelic medicines. The company, through collaborations with industry leading partners, is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechanisms to improve mental health and wellness. The company is also developing transformative medicines to treat Orphan diseases to benefit patients of all ages.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
Suite 1400-1199 West Hastings Street Vancouver BC V6E3T2
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Lobe Sciences Improves Balance Sheet
Lobe Sciences Improves Balance Sheet

09 Oct 2025

// ACCESSWIRE BIO

https://www.accessnewswire.com/newsroom/en/biotechnology/lobe-sciences-improves-balance-sheet-1084862

ACCESSWIRE BIO
09 Oct 2025

https://www.accessnewswire.com/newsroom/en/biotechnology/lobe-sciences-announces-341-425-cad-private-placement-for-general-corporate-purposes-1053925

ACCESSWIRE
29 Jul 2025

https://www.accessnewswire.com/newsroom/en/biotechnology/lobe-sciences-ltd.-engages-arcstone-securities-for-strategic-capital-markets-advisory-1053920

ACCESSWIRE
29 Jul 2025

https://www.accessnewswire.com/newsroom/en/biotechnology/lobe-sciences-announces-validation-of-european-unitary-patent-for-dha-based-compositi-1046502

ACCESSWIRE
08 Jul 2025

https://www.accessnewswire.com/newsroom/en/biotechnology/lobe-sciences-moves-forward-with-development-of-conjugated-psilocintm-following-april-1040803

ACCESSWIRE
17 Jun 2025

https://www.accessnewswire.com/newsroom/en/biotechnology/lobe-sciences-appoints-mr.-yong-yao-as-chief-financial-officer-to-support-strategic-g-1034471

ACCESSWIRE
03 Jun 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty